rs2066462

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The NM_005957.5(MTHFR):​c.1056C>T​(p.Ser352Ser) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.104 in 1,613,510 control chromosomes in the GnomAD database, including 9,138 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.097 ( 777 hom., cov: 32)
Exomes 𝑓: 0.10 ( 8361 hom. )

Consequence

MTHFR
NM_005957.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.561

Publications

43 publications found
Variant links:
Genes affected
MTHFR (HGNC:7436): (methylenetetrahydrofolate reductase) The protein encoded by this gene catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine. Genetic variation in this gene influences susceptibility to occlusive vascular disease, neural tube defects, colon cancer and acute leukemia, and mutations in this gene are associated with methylenetetrahydrofolate reductase deficiency.[provided by RefSeq, Oct 2009]
MTHFR Gene-Disease associations (from GenCC):
  • homocystinuria due to methylene tetrahydrofolate reductase deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 1-11794839-G-A is Benign according to our data. Variant chr1-11794839-G-A is described in ClinVar as Benign. ClinVar VariationId is 292238.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.561 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.149 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MTHFRNM_005957.5 linkc.1056C>T p.Ser352Ser synonymous_variant Exon 7 of 12 ENST00000376590.9 NP_005948.3 P42898-1Q8IU67Q59GJ6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MTHFRENST00000376590.9 linkc.1056C>T p.Ser352Ser synonymous_variant Exon 7 of 12 1 NM_005957.5 ENSP00000365775.3 P42898-1

Frequencies

GnomAD3 genomes
AF:
0.0973
AC:
14805
AN:
152120
Hom.:
776
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0882
Gnomad AMI
AF:
0.0482
Gnomad AMR
AF:
0.0674
Gnomad ASJ
AF:
0.0326
Gnomad EAS
AF:
0.119
Gnomad SAS
AF:
0.158
Gnomad FIN
AF:
0.128
Gnomad MID
AF:
0.0380
Gnomad NFE
AF:
0.104
Gnomad OTH
AF:
0.0826
GnomAD2 exomes
AF:
0.0987
AC:
24778
AN:
251112
AF XY:
0.101
show subpopulations
Gnomad AFR exome
AF:
0.0804
Gnomad AMR exome
AF:
0.0636
Gnomad ASJ exome
AF:
0.0321
Gnomad EAS exome
AF:
0.118
Gnomad FIN exome
AF:
0.118
Gnomad NFE exome
AF:
0.0993
Gnomad OTH exome
AF:
0.0893
GnomAD4 exome
AF:
0.104
AC:
152424
AN:
1461272
Hom.:
8361
Cov.:
35
AF XY:
0.105
AC XY:
76360
AN XY:
726860
show subpopulations
African (AFR)
AF:
0.0802
AC:
2685
AN:
33472
American (AMR)
AF:
0.0638
AC:
2851
AN:
44714
Ashkenazi Jewish (ASJ)
AF:
0.0333
AC:
871
AN:
26128
East Asian (EAS)
AF:
0.105
AC:
4176
AN:
39682
South Asian (SAS)
AF:
0.143
AC:
12323
AN:
86246
European-Finnish (FIN)
AF:
0.114
AC:
6097
AN:
53360
Middle Eastern (MID)
AF:
0.0449
AC:
259
AN:
5764
European-Non Finnish (NFE)
AF:
0.105
AC:
116826
AN:
1111548
Other (OTH)
AF:
0.105
AC:
6336
AN:
60358
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
7351
14702
22053
29404
36755
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4332
8664
12996
17328
21660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0974
AC:
14825
AN:
152238
Hom.:
777
Cov.:
32
AF XY:
0.0985
AC XY:
7329
AN XY:
74438
show subpopulations
African (AFR)
AF:
0.0884
AC:
3672
AN:
41546
American (AMR)
AF:
0.0674
AC:
1032
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.0326
AC:
113
AN:
3468
East Asian (EAS)
AF:
0.119
AC:
616
AN:
5168
South Asian (SAS)
AF:
0.158
AC:
763
AN:
4828
European-Finnish (FIN)
AF:
0.128
AC:
1356
AN:
10600
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.104
AC:
7041
AN:
68000
Other (OTH)
AF:
0.0827
AC:
175
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
690
1381
2071
2762
3452
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0944
Hom.:
329
Bravo
AF:
0.0891
Asia WGS
AF:
0.128
AC:
443
AN:
3478
EpiCase
AF:
0.0931
EpiControl
AF:
0.0872

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Apr 25, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Homocystinuria due to methylene tetrahydrofolate reductase deficiency Benign:3
Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 01, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.44
CADD
Benign
9.1
DANN
Benign
0.79
PhyloP100
-0.56
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2066462; hg19: chr1-11854896; COSMIC: COSV64876888; COSMIC: COSV64876888; API